LV11882A - Aminotetralina atvasinajumi sirds un asinsvadu slimibu arstesana - Google Patents

Aminotetralina atvasinajumi sirds un asinsvadu slimibu arstesana

Info

Publication number
LV11882A
LV11882A LV970166A LV970166A LV11882A LV 11882 A LV11882 A LV 11882A LV 970166 A LV970166 A LV 970166A LV 970166 A LV970166 A LV 970166A LV 11882 A LV11882 A LV 11882A
Authority
LV
Latvia
Prior art keywords
cardiovascular disease
disease treatment
aminotetralin derivatives
aminotetralin
derivatives
Prior art date
Application number
LV970166A
Other languages
English (en)
Other versions
LV11882B (lv
Inventor
Paolo Chiesi
Stefano Bongrani
Roberta Razzetti
Maurizio Civelli
Alberto Umile
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of LV11882A publication Critical patent/LV11882A/lv
Publication of LV11882B publication Critical patent/LV11882B/lv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LVP-97-166A 1995-03-17 1997-09-15 Aminotetralīna atvasinājumi sirds un asinsvadu slimību ārstēšanā LV11882B (lv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT95MI000532A IT1275935B1 (it) 1995-03-17 1995-03-17 Derivato di aminotetralina per la terapia di malattie cardiovascolari
PCT/EP1996/001060 WO1996029065A2 (en) 1995-03-17 1996-03-13 Aminotetralin derivative for the therapy of cardiovascular diseases

Publications (2)

Publication Number Publication Date
LV11882A true LV11882A (lv) 1997-12-20
LV11882B LV11882B (lv) 1998-03-20

Family

ID=11370947

Family Applications (1)

Application Number Title Priority Date Filing Date
LVP-97-166A LV11882B (lv) 1995-03-17 1997-09-15 Aminotetralīna atvasinājumi sirds un asinsvadu slimību ārstēšanā

Country Status (31)

Country Link
US (2) US6013678A (lv)
EP (2) EP0814791B1 (lv)
JP (1) JPH11502211A (lv)
KR (1) KR100391143B1 (lv)
CN (1) CN1112920C (lv)
AT (1) ATE218856T1 (lv)
AU (1) AU702656B2 (lv)
BR (1) BR9607996A (lv)
CA (1) CA2215671A1 (lv)
CZ (1) CZ288488B6 (lv)
DE (1) DE69621786T2 (lv)
DK (1) DK0814791T3 (lv)
EA (1) EA000937B1 (lv)
EE (1) EE04040B1 (lv)
ES (1) ES2177769T3 (lv)
HK (2) HK1004802A1 (lv)
HU (1) HUP9801686A3 (lv)
IL (1) IL117518A (lv)
IT (1) IT1275935B1 (lv)
LT (1) LT4355B (lv)
LV (1) LV11882B (lv)
MX (1) MX9706971A (lv)
NO (1) NO317402B1 (lv)
NZ (1) NZ303993A (lv)
PL (1) PL183347B1 (lv)
PT (1) PT814791E (lv)
SI (1) SI9620036B (lv)
SK (1) SK282952B6 (lv)
TR (1) TR199700963T1 (lv)
WO (1) WO1996029065A2 (lv)
ZA (1) ZA962073B (lv)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2695157B2 (ja) * 1986-12-29 1997-12-24 松下電器産業株式会社 可変パイプラインプロセッサ
WO2000076544A1 (en) * 1996-03-13 2000-12-21 Chiesi Farmaceutici S.P.A. Aminotetralin derivative for the therapy of cardiovascular diseases
EP1331004A3 (en) * 1999-06-09 2003-08-06 CHIESI FARMACEUTICI S.p.A. Aminotetralin Derivative for the Therapy of Cardiovascular Diseases
AU766230B2 (en) * 1999-06-09 2003-10-09 Chiesi Farmaceutici S.P.A. Aminotetralin derivative for the therapy of cardiovascular diseases
IT1313583B1 (it) * 1999-07-30 2002-09-09 Chiesi Farma Spa Derivati 2-amminotetralinici per la terapia del glaucoma.
IL152751A0 (en) * 2000-05-12 2003-06-24 Chiesi Farma Spa Optically active 2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them
SE0101854L (sv) * 2001-05-28 2002-11-29 Bioneris Ab Användning av en förening med en negativt laddad region av grupper för behandling av restenos.
EP1384708A1 (en) * 2002-07-26 2004-01-28 CHIESI FARMACEUTICI S.p.A. Process for the manufacture of form I of nolomirole hydrochloride
US20050101668A1 (en) * 2003-07-24 2005-05-12 Chiesi Farmaceutici S.P.A. Aminotetralin derivatives as a medicament for the treatment and prevention of myocardial ischemic conditions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4134997A (en) * 1977-03-01 1979-01-16 University Of Iowa Research Foundation Effect of an aminotetralin derivative on coronary blood flow in infarcted hearts
SU998342A1 (ru) 1981-12-11 1983-02-23 Предприятие П/Я А-3732 Способ получени синтетического цеолита типа @
IT1218322B (it) * 1982-06-10 1990-04-12 Chiesi Farma Spa Derivati di 1,2,3,4-tetraidronaftalene,procedimento di preparazione e relative composizioni farmaceutiche

Also Published As

Publication number Publication date
JPH11502211A (ja) 1999-02-23
AU5107296A (en) 1996-10-08
PT814791E (pt) 2002-10-31
LV11882B (lv) 1998-03-20
DK0814791T3 (da) 2002-10-07
SK125497A3 (en) 1998-02-04
MX9706971A (es) 1997-11-29
HUP9801686A2 (hu) 1999-06-28
SI9620036A (sl) 1998-02-28
EE9700231A (et) 1998-04-15
PL183347B1 (pl) 2002-06-28
NO317402B1 (no) 2004-10-25
KR100391143B1 (ko) 2003-11-28
IT1275935B1 (it) 1997-10-24
CZ286697A3 (cs) 1998-03-18
CN1181699A (zh) 1998-05-13
LT4355B (lt) 1998-06-25
HK1004802A1 (en) 1998-12-11
ES2177769T3 (es) 2002-12-16
CN1112920C (zh) 2003-07-02
AU702656B2 (en) 1999-02-25
NZ303993A (en) 2000-12-22
US6103760A (en) 2000-08-15
HK1048060A1 (zh) 2003-03-21
LT97147A (en) 1998-02-25
EP0814791B1 (en) 2002-06-12
EP1216702A2 (en) 2002-06-26
EP0814791A1 (en) 1998-01-07
TR199700963T1 (xx) 1998-02-21
EP1216702A3 (en) 2002-09-04
ATE218856T1 (de) 2002-06-15
CZ288488B6 (en) 2001-06-13
ZA962073B (en) 1996-11-27
NO974267L (no) 1997-11-07
ITMI950532A1 (it) 1996-09-17
US6013678A (en) 2000-01-11
ITMI950532A0 (it) 1995-03-17
SI9620036B (sl) 2002-10-31
HUP9801686A3 (en) 1999-10-28
WO1996029065A2 (en) 1996-09-26
SK282952B6 (sk) 2003-01-09
EE04040B1 (et) 2003-06-16
EA199700243A1 (ru) 1998-02-26
CA2215671A1 (en) 1996-09-26
NO974267D0 (no) 1997-09-16
EA000937B1 (ru) 2000-06-26
WO1996029065A3 (en) 1996-11-28
KR19980703030A (ko) 1998-09-05
BR9607996A (pt) 1998-06-23
DE69621786D1 (de) 2002-07-18
IL117518A0 (en) 1996-07-23
IL117518A (en) 2001-05-20
PL322284A1 (en) 1998-01-19
DE69621786T2 (de) 2003-01-02

Similar Documents

Publication Publication Date Title
KR960702318A (ko) 근육 질병 및 장애의 치료방법
BR9714363A (pt) Derivados de pirazol substituìdos para o tratamento de doenças circulatórias cardìacas
ITTO950104A0 (it) Catetere, particolarmente per il trattamento di aritmie cardiache.
IE791235L (en) Acyl-derivatives of carnitine.
DE69814394D1 (de) Verwendung von levobupivacain
LV11882A (lv) Aminotetralina atvasinajumi sirds un asinsvadu slimibu arstesana
ITTO950099A0 (it) Catetere, particolarmente per il trattamento di aritmie cardiache.
DE69302544D1 (de) 2-amino-1,2,3,4-tetrahydronaphthalen derivate mit wirkung auf das kardiovasculäre system, verfahren zu deren herstellung und deren pharmazeutische zusammensetzungen
DE69018099T2 (de) Polyamin-Derivate als antineoplastische Mittel.
KR100194995B1 (ko) 관상동맥성 심장질환,동맥경화증 및(또는)지방단백질 대사 이상 치료용 약제
EP0576913A3 (en) Digitoxigenin and dihydrodigitoxigenin 3-beta derivatives and pharmaceutical preparations thereof, for the treatment of cardiovascular diseases.
GR3029466T3 (en) 1,5-disubstituted 7a-methylperhydroinden-3a-ol derivatives, active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them
IT9048106A0 (it) Associazione medicamentosa per il trattamento dell'ipertensione e dell'insufficienza cardiaca congestiva. (caso 100-7516)
IT8421753A0 (it) Agenti terapeutici per il trattamento di disturbi cardiaci edella circolazione, delle dislipidemie e delle deficienze delle prestazioni muscolari, procedimento per la loro preparazione e relative composizioni farmaceutiche.
ITMI950956A0 (it) Uso degli enantiomeri (s) di derivati 1,4-diidropiridinici per il trattamento dell'insufficienza cardiaca
DE500713T1 (de) Derivate des 3,3,5-trimethylcyclohexylesters von 2-methylpropionsaeure, ihr herstellungsverfahren sowie diese enthaltende therapeutische kompositionen.